Insiders · Profile

HEGGIE THERESA

Director at BIOCRYST PHARMACEUTICALS. Filing since 18 Nov 2019. CIK 0001760020

Company
Date
Role
Action
Shares
Amount
Of holding
20 Mar 2026
Director
Sold at will
49,933
$504.82K
43.3%
13 Aug 2025
Director
Sold at will
70,000
$595.87K
51.7%
14 Jun 2024
Director
Sold at will
6,698
$40.92K
11.2%
18 Nov 2019
Director
Bought
5,000
$7.25K
299%
4 decisions on file.